Abstract
Angioinvasive fungal infections have a significant morbidity and mortality in the immunocompromised host. Massive burns produce a profound derangement in cellular immunity along with a loss of cutaneous barrier function. Treatment of fungal burn wound infections poses a difficult therapeutic challenge. We present a new method of treatment for angioinvasive fungal infections with nystatin powder at a concentration of 6,000,000 units/g. It proved to be efficacious in four consecutive severely burned patients affected by massive angioinvasive fungal infection. Both superficial and deep tissue infections were eradicated without any other therapeutic interventions or adverse effects on wound healing.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 505-508 |
| Number of pages | 4 |
| Journal | Burns |
| Volume | 25 |
| Issue number | 6 |
| DOIs | |
| State | Published - Sep 1 1999 |
Keywords
- Aspergillus
- Burns
- Fusarium
- Nystatin
ASJC Scopus subject areas
- Surgery
- Emergency Medicine
- Critical Care and Intensive Care Medicine
Fingerprint Dive into the research topics of 'Topical nystatin powder in severe burns: A new treatment for angioinvasive fungal infections refractory to other topical and systemic agents'. Together they form a unique fingerprint.
Cite this
Barret, J. P., Ramzy, P. I., Heggers, J. P., Villareal, C., Herndon, D. N., & Desai, M. H. (1999). Topical nystatin powder in severe burns: A new treatment for angioinvasive fungal infections refractory to other topical and systemic agents. Burns, 25(6), 505-508. https://doi.org/10.1016/S0305-4179(99)00037-6